Page last updated: 2024-10-20

spermidine and Multiple System Atrophy

spermidine has been researched along with Multiple System Atrophy in 1 studies

Multiple System Atrophy: A syndrome complex composed of three conditions which represent clinical variants of the same disease process: STRIATONIGRAL DEGENERATION; SHY-DRAGER SYNDROME; and the sporadic form of OLIVOPONTOCEREBELLAR ATROPHIES. Clinical features include autonomic, cerebellar, and basal ganglia dysfunction. Pathologic examination reveals atrophy of the basal ganglia, cerebellum, pons, and medulla, with prominent loss of autonomic neurons in the brain stem and spinal cord. (From Adams et al., Principles of Neurology, 6th ed, p1076; Baillieres Clin Neurol 1997 Apr;6(1):187-204; Med Clin North Am 1999 Mar;83(2):381-92)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Paik, MJ1
Ahn, YH1
Lee, PH1
Kang, H1
Park, CB1
Choi, S1
Lee, G1

Other Studies

1 other study available for spermidine and Multiple System Atrophy

ArticleYear
Polyamine patterns in the cerebrospinal fluid of patients with Parkinson's disease and multiple system atrophy.
    Clinica chimica acta; international journal of clinical chemistry, 2010, Oct-09, Volume: 411, Issue:19-20

    Topics: Aged; Biomarkers; Cerebrospinal Fluid; Female; Gas Chromatography-Mass Spectrometry; Humans; Male; M

2010